Patent ID: 11957736
Assignee: XERIS PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 2:
3. The method of claim 2, wherein the components of the device flow path comprise polycarbonate (PC), acrylonitrile butadiene styrene (ABS), meta-acrylonitrile butadiene styrene (MABS), methylcellulose, carboxymethylcellulose sodium, dextrin, ethylcellulose, hydroxyethyl cellulose, hydroxypropyl methylcellulose, maltodextrin, polymethacrylates, polystyrene (PS), polyisobutylene (PIB), polymethyl methacrylate (PMMA), ethylene vinyl acetate (EVA), polyvinyl chloride (PVC), thermoplastic polyurethane (TPU), hydroxypropyl methyl cellulose (HPMC), high density polyethylene (HDPE), low density polyethylene (LDPE), polyurethane, or blends thereof.